Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 119

Similar articles for PubMed (Select 15509742)

1.

Mapping dopamine function in primates using pharmacologic magnetic resonance imaging.

Jenkins BG, Sanchez-Pernaute R, Brownell AL, Chen YC, Isacson O.

J Neurosci. 2004 Oct 27;24(43):9553-60.

2.

Mapping of brain function after MPTP-induced neurotoxicity in a primate Parkinson's disease model.

Brownell AL, Canales K, Chen YI, Jenkins BG, Owen C, Livni E, Yu M, Cicchetti F, Sanchez-Pernaute R, Isacson O.

Neuroimage. 2003 Oct;20(2):1064-75.

PMID:
14568476
3.

Mapping dopamine D2/D3 receptor function using pharmacological magnetic resonance imaging.

Chen YC, Choi JK, Andersen SL, Rosen BR, Jenkins BG.

Psychopharmacology (Berl). 2005 Aug;180(4):705-15. Epub 2005 Sep 14.

PMID:
15536545
4.

Objective and quantitative evaluation of motor function in a monkey model of Parkinson's disease.

Saiki H, Hayashi T, Takahashi R, Takahashi J.

J Neurosci Methods. 2010 Jul 15;190(2):198-204. doi: 10.1016/j.jneumeth.2010.05.009. Epub 2010 May 19.

PMID:
20488205
5.

Selective dopamine D(3) receptor antagonist SB-277011-A potentiates phMRI response to acute amphetamine challenge in the rat brain.

Schwarz A, Gozzi A, Reese T, Bertani S, Crestan V, Hagan J, Heidbreder C, Bifone A.

Synapse. 2004 Oct;54(1):1-10.

PMID:
15300879
6.

Overlesioned hemiparkinsonian non human primate model: correlation between clinical, neurochemical and histochemical changes.

Oiwa Y, Eberling JL, Nagy D, Pivirotto P, Emborg ME, Bankiewicz KS.

Front Biosci. 2003 Sep 1;8:a155-66.

PMID:
12957824
7.

Changes in brain catecholamines and dopamine uptake sites at different stages of MPTP parkinsonism in monkeys.

Alexander GM, Schwartzman RJ, Brainard L, Gordon SW, Grothusen JR.

Brain Res. 1992 Aug 21;588(2):261-9.

PMID:
1356591
8.
9.

Estradiol and brain serotonin reuptake transporter in long-term ovariectomized parkinsonian monkeys.

Sánchez MG, Morissette M, Di Paolo T.

Prog Neuropsychopharmacol Biol Psychiatry. 2013 Aug 1;45:170-7. doi: 10.1016/j.pnpbp.2013.05.008. Epub 2013 May 26.

PMID:
23719069
10.

Cocaine congeners as PET imaging probes for dopamine terminals.

Brownell AL, Elmaleh DR, Meltzer PC, Shoup TM, Brownell GL, Fischman AJ, Madras BK.

J Nucl Med. 1996 Jul;37(7):1186-92.

11.

Effect of age on markers for monoaminergic neurons of normal and MPTP-lesioned rhesus monkeys: a multi-tracer PET study.

Doudet DJ, Rosa-Neto P, Munk OL, Ruth TJ, Jivan S, Cumming P.

Neuroimage. 2006 Mar;30(1):26-35. Epub 2005 Dec 27.

PMID:
16378735
12.

Mapping interactions between dopamine and adenosine A2a receptors using pharmacologic MRI.

Chen YI, Choi JK, Jenkins BG.

Synapse. 2005 Feb;55(2):80-8.

PMID:
15529335
13.

Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.

Pellegrino D, Cicchetti F, Wang X, Zhu A, Yu M, Saint-Pierre M, Brownell AL.

J Nucl Med. 2007 Jul;48(7):1147-53. Epub 2007 Jun 15.

14.

GDNF improves dopamine function in the substantia nigra but not the putamen of unilateral MPTP-lesioned rhesus monkeys.

Gerhardt GA, Cass WA, Huettl P, Brock S, Zhang Z, Gash DM.

Brain Res. 1999 Jan 30;817(1-2):163-71.

PMID:
9889359
15.

Restoration of dopamine transporter density in the striatum of fetal ventral mesencephalon-grafted, but not sham-grafted, MPTP-treated parkinsonian monkeys.

Elsworth JD, Brittan MS, Taylor JR, Sladek JR Jr, al-Tikriti MS, Zea-Ponce Y, Innis RB, Redmond DE Jr, Roth RH.

Cell Transplant. 1996 Mar-Apr;5(2):315-25.

PMID:
8689042
16.

Metabotropic glutamate receptor 5 antagonist protects dopaminergic and noradrenergic neurons from degeneration in MPTP-treated monkeys.

Masilamoni GJ, Bogenpohl JW, Alagille D, Delevich K, Tamagnan G, Votaw JR, Wichmann T, Smith Y.

Brain. 2011 Jul;134(Pt 7):2057-73. doi: 10.1093/brain/awr137.

17.

Effect of MPTP-induced denervation on basal ganglia GABA(B) receptors: correlation with dopamine concentrations and dopamine transporter.

Calon F, Lavertu N, Lemieux AM, Morissette M, Goulet M, Grondin R, Blanchet PJ, Bédard PJ, Di Paolo T.

Synapse. 2001 Jun 1;40(3):225-34.

PMID:
11304760
18.

Neurotensin receptors and dopamine transporters: effects of MPTP lesioning and chronic dopaminergic treatments in monkeys.

Goulet M, Morissette M, Grondin R, Falardeau P, Bédard PJ, Rostène W, Di Paolo T.

Synapse. 1999 Jun 1;32(3):153-64.

PMID:
10340626
19.
20.

Dopamine fiber detection by [11C]-CFT and PET in a primate model of parkinsonism.

Hantraye P, Brownell AL, Elmaleh D, Spealman RD, Wüllner U, Brownell GL, Madras BK, Isacson O.

Neuroreport. 1992 Mar;3(3):265-8.

PMID:
1515582
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk